glp 1 ibd More encouraging news about GLP-1 medications. New research presented at ASCO found that patients with inflammatory bowel disease (IBD) who used GLP- receptor agonists had a 51% lower odds of developing colorectal Gut Hormones and Inflammatory Bowel

Results The result shows alteration in testicular and epididymis weight and testis/epididymis ratio, semen parameters, sperm capacitation and acrosome reaction, sperm DNA, serum Zn and Mg, testicular mitochondria apoptosis mechanisms (TNF- and BCL-2), and testicularCa-ATPaseas well as fecundity outcome in the phthalate-treated group

The three-way comparison between semaglutide, tirzepatide, and retatrutide continues to evolve as more clinical data becomes available

Each color performs its function perfectly

GLP-1 receptor agonists mimic that hormone

Treatment with the testosterone patch significantly improved sexual activity and sexual desire and decreased personal distress

On a 1 mL insulin syringe (100 units), every 20 units equals 1 mg